Trial Profile
Efficacy and Safety of a Post-transplantation Switch From Cyclosporin to Tacrolimus Sustained-release Capsules in Renal Transplant Recipients: A Multi-center, Open-label, Uncontrolled Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2022
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma China
- 14 Mar 2016 New trial record